Filing Details
- Accession Number:
- 0001062993-16-011354
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-30 19:16:58
- Reporting Period:
- 2016-08-29
- Filing Date:
- 2016-08-30
- Accepted Time:
- 2016-08-30 19:16:58
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875622 | Biospecifics Technologies Corp | BSTC | Pharmaceutical Preparations (2834) | 113054851 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1355189 | Thomas Wegman | C/O Biospecifics Technologies Corp. 35 Wilbur Street Lynbrook NY 11563 | President | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.001 Par Value | Disposition | 2016-08-29 | 1,607 | $37.61 | 978,571 | No | 4 | S | Indirect | See footnote |
Common Stock, $.001 Par Value | Disposition | 2016-08-30 | 2,692 | $37.50 | 975,879 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- The selling price of $37.6107 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.51 to $37.625. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The selling price of $37.5027 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $37.5005 to $37.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- These shares are held in trust on behalf of the reporting person and Ms. Toby Wegman. The reporting person is the co-trustee of the trust with Ms. Toby Wegman. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.